The paper presents the results of percutaneous coronary intervention for acute myocardial infarction in patients with concomitant diabetes mellitus. The study was performed by analyzing the results of examination and treatment of 86 patients aged 68,9 ± 9,3 years with acute myocardial infarction who underwent percutaneous coronary intervention in the first days of its development. The study group included 48 people suffering from type 2 diabetes mellitus. The control group included 38 patients without disorders of carbohydrate metabolism. It is proved that percutaneous coronary intervention in the treatment of acute myocardial infarction in patients with concomitant type 2 diabetes allows to obtain a comparable data with group of patients without concomitant diabetes mellitus direct and immediate results in the number of major adverse events, which proves the efficacy and safety of this method of reperfusion. It was revealed that during the late postoperative period in patients with acute myocardial infarction and concomitant diabetes there is increase incidence of repeat revascularization in the non-target stenosis as a result of a rare achieve complete revascularization during primary percutaneous coronary intervention. The authors proposed a comprehensive early myocardial revascularization (within 2-4 weeks after primary percutaneous coronary intervention) as the most appropriate approach in the staged treatment of patients with acute myocardial infarction and concomitant diabetes.
diabetes mellitus, myocardium acute infarction, percutaneous coronary intervention.
1. Adamyan K.G., Chilingaryan A.L., Martirosyan M.D. Prognosticheskaya znachimost´ shkaly riska GRACE v kratkosrochnom i dolgosrochnom prognozirovanii ostrogo koronarnogo sindroma. Meditsin-skaya nauka Armenii NAN RA. 2014. T. LIV, №1. S. 3-8.
2. Barbarash L.S., Sin´kov M.A., Ganyukov V.I., Evtushenko S.A., Bokhan N.S., Barbarash O.L. Re-zul´taty pervichnoy ChKV u bol´nykh IM s pod´´emom segmenta ST i soputstvuyushchim mul´tifokal´nym aterosklerozom. Mezhdunarodnyy zhurnal interventsionnoy kardioangiologii. 2010. №21. S. 37-40.
3. Bokeriya L.A., Alekyan B.G., Buziashvili Yu.I., Golukhova E.Z., Staferov A.V., Asymbekova E.U., Zakaryan N.V., Kazaryan A.G. Neposredstvennye i otdalennye rezul´taty stentirovaniya koronarnykh arteriy u bol´nykh IBS i sakharnym diabetom 2 tipa. Grudnaya i ser¬dechno-sosudistaya khirurgiya. 2009, № 3. S. 36-44.
4. Dedov I.I., Shestakova M.V., Galstyan G.R. Algoritmy spetsializirovannoy meditsinskoy po-moshchi bol´nym sakharnym diabetom. Pod redaktsiey I.I. Dedova, M.V. Shestakovoy (7-y vypusk).. Sa-kharnyy diabet. 2015. T.18, №1. S. 1-112.
5. Makisheva R.T., Khadartsev A.A., Khromushin V.A., Dail´nev V.I. Vozrastnoy analiz smertnosti naseleniya Tul´skoy oblasti ot sakharnogo diabeta. Vestnik novykh meditsinskikh tekhnologiy. Elektronnoe izdanie. 2014. № 1. Publikatsiya: 7-9. URL: http://www.medtsu.tula.ru/VNMT/Bulletin/E2014-1/4900.pdf (data obrashcheniya: 27.08.2014). DOI:https://doi.org/10.12737/5613.
6. Oganov R.G. Maslennikova G.Ya. Dostizheniya i neudachi v profilaktike serdechno-sosudistykh zabolevaniy. Kardiovaskulyarnaya terapiya i profilaktika. 2014. №1. S 4-7.
7. Panova E.I., Kruglova N.E., Strongin L.G., Kochenyuk O.A. Osobennosti i prognosticheskaya znachimost´ simpatoadrenalovoy aktivnosti u bol´nykh infarktom miokarda i sakharnym diabetom 2 tipa. Sovremennye tekhnologii v meditsine. 2011. №2. S. 81-84.
8. Khadartsev A.A., Smolenskiy A.V., Makisheva R.T., Prilepa S.N. Mekhanizmy adaptatsii i ikh korrektsiya v klinike vnutrennikh bolezney pri sakharnom diabete 2 tipa. Terapevt. 2014. № 10. S. 46-49.
9. Khromushin V.A., Khadartsev A.A., Andreeva Yu.V., Lastovetskiy A.G. Otsenka smertnosti nasele-niya Tul´skoy oblasti. Vestnik novykh meditsinskikh tekhnologiy. Elektronnoe izdanie. 2014. №1. Pub-likatsiya 7-7. URL: http://www.medtsu.tula.ru/VNMT/Bulletin/E2014-1/4898.pdf (Data obrashcheniya 26.08.2014). DOI:https://doi.org/10.12737/5611
10. American Diabetes Association. Standards of medical care in diabetes - 2013.. Diabetes Care. 2013. 36 Suppl 1. R. 11-66.
11. Anand S.S., Dagenais G.R., Mohan V., Diaz R., Probstfield J., Freeman R., Shaw J., Lanas F., Avezum A., Budaj A., Jung H., Desai D., Bosch J., Yusuf S., Gerstein H.C. Glucose levels are associated with cardi-ovascular disease and death in an international cohort of normal glycaemic and dysglycaemic men and women: the EpiDREAM cohort study. Eur. J. Card. Prev. Rehab. 2012. 19. R. 755-764.
12. Papak J., Kansagara D. Management of hyperglycemia in a hospitalized patient with diabetes mellitus and cardiovascular disease. The American journal of cardiology. 2012. 110(9 Suppl). R. 24B-31B.
